v3.26.1
Acquisitions
 3 Months Ended
Apr. 30, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisitions Acquisitions
Ostro
On March 9, 2026, we acquired all outstanding stock of Rise Healthcare Tech, Inc. (“Ostro”) in exchange for a total consideration of $90 million, or $70 million net of cash acquired, which includes the impact of adjustments to purchase price associated with the net working capital of the acquired entity at close and excludes equity awards to certain Ostro employees that are accounted for separately from the business combination. Ostro provides an engagement platform for life sciences that gives patients and doctors immediate, compliant answers through an AI-driven chat.
The following table summarizes the estimated fair values of the identifiable intangible assets, useful lives, and goodwill at the acquisition date (in thousands):
Useful lifeFair Value
Identifiable intangible assets:
Trade names and trademarks3 years$1,300 
Developed technology5 years14,500 
Customer relationships7 years9,700 
Total purchased intangible assets25,500 
Goodwill44,423 
Goodwill, which is not deductible for income tax purposes, is primarily attributed to the value expected from synergies resulting from the business combination.